Brief: China Biotech Services Sees Net Profit Attributable For Six Months Of Not Less Than Hk$65 Million
03/08/2022 15:39
Aug 3 (Reuters) - China Biotech Services 8037.HK :
* SEES NET PROFIT ATTRIBUTABLE FOR SIX MONTHS OF NOT LESS
THAN
HK$65 MILLION
* EXPECTED RESULT DUE TO ROBUST DEMANDS FOR RAPID ANTIGEN
TEST
KITS AND COVID-19 TESTING SERVICES
Further company coverage: 8037.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on China Biotech Services Holdings
See all newsBrief: China Biotech Services Enters Cooperation Agreement
Brief: China Biotech Services Says HY Revenue From Cont Ops Hk$37.23 Million
Brief: China Biotech Services Expects HY Net Profit Of Not Less Than HK$15.0 MLN
Brief: China Biotech Services Enters Master Collaboration Agreement With Stella Pharma
Brief: China Biotech Services Says BGI Songhe Advances RMB30 Million Loan To Pengbo (Hainan)